lawsuits
 

Zostavax Lawsuit

Open

Merck is facing lawsuits for its shingles vaccination, Zostavax. Plaintiffs allege that the vaccine caused eye disease, paralysis, and fatal liver failure.

 

Eliquis Lawsuit

Open

The blood thinner Eliquis may cause life-threatening internal bleeding. Eliquis users who suffered serious bleeding events are filing lawsuits.

 

Risperdal Lawsuit

Open

The antipsychotic drug Risperdal can cause boys to develop female breast tissue (gynecomastia). Thousands have filed lawsuits against Johnson & Johnson.

 

Invokana Lawsuit

Open

Invokana lawsuits claim that Janssen failed to warn that the diabetes drug could cause diabetic ketoacidosis (DKA) and other serious adverse side effects.

 

Opioid Lawsuit

Under Investigation

As a result of America's opioid epidemic, many addicts and their family members are filing lawsuits against physicians, pharmacists, and drug wholesalers.

 

Pradaxa Lawsuit

Open

The blood thinner Pradaxa did not have an antidote for its bleeding events until 2015, leading to hundreds of casualties and thousands of lawsuits.

 

Xarelto Lawsuit

Open

Did Bayer/Johnson & Johnson hype Xarelto benefits while downplaying its bleeding risks? That's what more than 5,000 Xarelto lawsuits claim.

 

Invega Lawsuit

Open

The antipsychotic drug Invega can cause boys to develop female breast tissue (gynecomastia). Hundreds have filed lawsuits against the manufacturer, Johnson & Johnson.

 

Testosterone Therapy Lawsuit

Open

Testosterone therapy manufacturers aggressively marketed their products to men and did not properly warn of cardiovascular side effects, according to lawsuits.

 

Onglyza Lawsuit

Open

Onglyza and Kombiglyze XR lawsuits allege that drugmaker AstraZeneca for years knew about heart failure risks but failed to adequately warn doctors and patients.

 

Abilify Lawsuit

Open

The companies that manufacture and market Abilify failed to warn U.S. patients that the drug could induce compulsive behaviors like gambling.

 

Taxotere Lawsuit

Open

Lawsuits allege that drugmaker Sanofi hid Taxotere's permanent hair loss risks while falsely and illegally promoting the drug to increase profits.

Next Page